Скачать или смотреть Webinar: Thinking Beyond Sugar in Diabetes

Smoking cessation and cardiovascular risk reduction in patients with diabetes

Tobacco is the leading cause of preventable death. It affects nearly every organ in the body. Tobacco use in Canada has decreased significantly from historic highs in the 1960’s but have stabilized over the last few years with 15.8% of Canadians 12 years of age and older being a daily or occasional smoker.

Cardiovascular disease and macrovascular complications are the leading cause of death in people with type 2 diabetes. Diabetes guidelines stress the importance of complication risk reduction in patients with diabetes and to not solely focus on glycemic control.

This presentation focuses on cardiovascular risk reduction in patients with type 2 diabetes. It stresses on the importance on smoking cessation to prevent and reduce complication risk in people with diabetes. Practical tips are shared on how to manage people with type 2 diabetes who use tobacco. It reviews the current recommendations to reduce cardiovascular risk in this large patient population.

Learning Objectives
1. Review the impact of tobacco use in people with prediabetes and diabetes
2. Ensure people with type 2 know their ABCDESSS to reduce their cardiovascular risk
3. Determine effective methods of approaching the topic of smoking cessation in individuals who use tobacco
4. Review the different pharmacotherapy options to improve smoking cessation rates in people with diabetes
5. Discuss the strategies to reduce cardiovascular risk in people with type 2 diabetes

Faculty
Michael Boivin is a clinical pharmacist consultant, continuing education developer and president of CommPharm Consulting Inc. He has developed in excess of 400 different continuing education activities for pharmacists, family physicians, physician specialists, nurses and other allied professionals. Michael attained his Certified Diabetes Educator (CDE) and Certified Tobacco Educator (CTE) status in 2014. He obtained his Certificate in Travel Health (CTH®) from the International Society of Travel Medicine in 2015.

The presentation slides are available for download: https://www.cpha.ca/sites/default/fil...

Funding Acknowledgement
This webinar is hosted by CPHA with support from Johnson & Johnson, a sponsor of the 2020 Tobacco and Vaping Control Forum.